Your browser doesn't support javascript.
loading
Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden.
Bröms, Gabriella; Kieler, Helle; Ekbom, Anders; Gissler, Mika; Hellgren, Karin; Lahesmaa-Korpinen, Anna-Maria; Pedersen, Lars; Schmitt-Egenolf, Marcus; Sørensen, Henrik T; Granath, Fredrik.
Afiliación
  • Bröms G; Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet and Department of Internal Medicine, Danderyd Hospital, Stockholm, Sweden.
  • Kieler H; Centre for Pharmacoepidemiology, Department of Medicine Solna and Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Ekbom A; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska institutet, Stockholm, Sweden.
  • Gissler M; Information Services Department, THL National Institute for Health and Welfare, Helsinki, Finland and Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
  • Hellgren K; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska institutet, Stockholm, Sweden.
  • Lahesmaa-Korpinen AM; Information Services Department, THL National Institute for Health and Welfare, Helsinki, Finland.
  • Pedersen L; Department of Clinical Epidemiology, Aarhus University, Denmark.
  • Schmitt-Egenolf M; Dermatology, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Sørensen HT; Department of Clinical Epidemiology, Aarhus University, Denmark.
  • Granath F; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska institutet, Stockholm, Sweden.
Pharmacoepidemiol Drug Saf ; 29(3): 316-327, 2020 03.
Article en En | MEDLINE | ID: mdl-32020767
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resultado del Embarazo / Factor de Necrosis Tumoral alfa / Adalimumab / Etanercept Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Infant / Newborn / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2020 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resultado del Embarazo / Factor de Necrosis Tumoral alfa / Adalimumab / Etanercept Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Infant / Newborn / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2020 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido